Background: Familial hypercholesterolemia is a common, inherited, life-threatening and
treatable condition that is characterized by marked elevations of low-density lipoprotein …

Background Pediatric lipid management recommendations have evolved from selective
screening to universal screening to identify and target therapy for genetic dyslipidemias …

Background: The 2011 NHLBI Integrated Pediatric Guidelines for cardiovascular risk
reduction advocate universal lipid screening to get treatment to the 0.2% of children with …

The pediatric lipid screening and treatment practices, attitudes, and perceived barriers of
Canadian pediatricians are not known. We sought to evaluate this in a survey of …

Identification and management of dyslipidemia in childhood can reduce future
cardiovascular risk. We performed a retrospective cohort study of children ages 2 to 18 years …

Background Early identification and treatment of individuals with elevated levels of
atherogenic cholesterol have been shown to be effective and safe in reducing morbidity and …

OBJECTIVES: The goal was to determine the sensitivity and specificity of family history in
identifying children with severe or genetic hyperlipidemias in a rural, predominantly white …

Background—Integrated guidelines on cardiovascular health and risk reduction in children
issued in 2011 newly recommended universal screening for dyslipidemia in children at 9 to …

In 2011, universal lipid screening was recommended for children aged 9 to 11 years; the
impact of this recommendation on the lipid clinic setting is unknown. We examined the rate …

Background Early diagnosis and treatment of familial hypercholesterolemia reduces patient
morbidity and mortality associated with coronary heart disease. Despite guidelines …